133 related articles for article (PubMed ID: 34778263)
1. Mechanism of stepwise electron transfer in six-transmembrane epithelial antigen of the prostate (STEAP) 1 and 2.
Chen K; Wang L; Shen J; Tsai AL; Zhou M; Wu G
Elife; 2023 Nov; 12():. PubMed ID: 37983176
[TBL] [Abstract][Full Text] [Related]
2. STEAP1-4 (Six-Transmembrane Epithelial Antigen of the Prostate 1-4) and Their Clinical Implications for Prostate Cancer.
Xu M; Evans L; Bizzaro CL; Quaglia F; Verrillo CE; Li L; Stieglmaier J; Schiewer MJ; Languino LR; Kelly WK
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011027
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory response in gastrointestinal cancers: Overview of six transmembrane epithelial antigens of the prostate in pathophysiology and clinical implications.
Fang ZX; Chen WJ; Wu Z; Hou YY; Lan YZ; Wu HT; Liu J
World J Clin Oncol; 2024 Jan; 15(1):9-22. PubMed ID: 38292664
[TBL] [Abstract][Full Text] [Related]
4. A novel prognostic signature and therapy guidance for hepatocellular carcinoma based on STEAP family.
Fu D; Zhang X; Zhou Y; Hu S
BMC Med Genomics; 2024 Jan; 17(1):16. PubMed ID: 38191397
[TBL] [Abstract][Full Text] [Related]
5. STEAP4 inhibits cisplatin-induced chemotherapy resistance through suppressing PI3K/AKT in hepatocellular carcinoma.
Xie B; Zhong B; Zhao Z; Hu J; Yang J; Xie Y; Zhang J; Long J; Yang X; Li H
Cancer Metab; 2023 Dec; 11(1):26. PubMed ID: 38111065
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of acute myeloid leukemia cells to ferroptosis and evasion strategies.
Zhang H; Sun C; Sun Q; Li Y; Zhou C; Sun C
Front Mol Biosci; 2023; 10():1275774. PubMed ID: 37818101
[TBL] [Abstract][Full Text] [Related]
7. Immune responses of six-transmembrane epithelial antigen of the prostate 4 functions as a novel biomarker in gastric cancer.
Fang ZX; Hou YY; Wu Z; Wu BX; Deng Y; Wu HT; Liu J
World J Clin Oncol; 2023 Aug; 14(8):297-310. PubMed ID: 37700807
[TBL] [Abstract][Full Text] [Related]
8. Identification of STEAP3-based molecular subtype and risk model in ovarian cancer.
Zhao Z; Sun C; Hou J; Yu P; Wei Y; Bai R; Yang P
J Ovarian Res; 2023 Jun; 16(1):126. PubMed ID: 37386521
[TBL] [Abstract][Full Text] [Related]
9. STEAP1 Knockdown Decreases the Sensitivity of Prostate Cancer Cells to Paclitaxel, Docetaxel and Cabazitaxel.
Rocha SM; Nascimento D; Coelho RS; Cardoso AM; Passarinha LA; Socorro S; Maia CJ
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047621
[TBL] [Abstract][Full Text] [Related]
10. Specific Six-Transmembrane Epithelial Antigen of the Prostate 1 Capture with Gellan Gum Microspheres: Design, Optimization and Integration.
Batista-Silva J; Gomes D; Barroca-Ferreira J; Gallardo E; Sousa Â; Passarinha LA
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768273
[TBL] [Abstract][Full Text] [Related]
11. STEAP1 regulation and its influence modulating the response of LNCaP prostate cancer cells to bicalutamide, enzalutamide and apalutamide.
Rocha SM; Nascimento D; Cardoso AM; Passarinha L; Socorro S; Maia CJ
Mol Med Rep; 2023 Feb; 27(2):. PubMed ID: 36660947
[TBL] [Abstract][Full Text] [Related]
12. EFEMP1 binds to STEAP1 to promote osteosarcoma proliferation and invasion via the Wnt/β-catenin and TGF-β/Smad2/3 signal pathways.
Zhang D; Han S; Pan X; Li H; Zhao H; Gao X; Wang S
J Bone Oncol; 2022 Dec; 37():100458. PubMed ID: 36388640
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming landscape highlighted by dynamic transcriptomes in therapy-induced neuroendocrine differentiation.
Asberry AM; Liu S; Nam HS; Deng X; Wan J; Hu CD
Comput Struct Biotechnol J; 2022; 20():5873-5885. PubMed ID: 36382181
[TBL] [Abstract][Full Text] [Related]
14. STEAP2 promotes osteosarcoma progression by inducing epithelial-mesenchymal transition via the PI3K/AKT/mTOR signaling pathway and is regulated by EFEMP2.
Zhang D; Liu H; Wang W; Xu G; Yin C; Wang S
Cancer Biol Ther; 2022 Dec; 23(1):1-16. PubMed ID: 36316642
[TBL] [Abstract][Full Text] [Related]
15. Antibody-drug conjugates: beyond current approvals and potential future strategies.
Menon S; Parakh S; Scott AM; Gan HK
Explor Target Antitumor Ther; 2022; 3(2):252-277. PubMed ID: 36046842
[TBL] [Abstract][Full Text] [Related]
16. Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy.
Shin HG; Yang HR; Yoon A; Lee S
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628495
[TBL] [Abstract][Full Text] [Related]
17. Current Advances in Aptamer-based Biomolecular Recognition and Biological Process Regulation.
Chen S; Zhang L; Yuan Q; Tan J
Chem Res Chin Univ; 2022; 38(4):847-855. PubMed ID: 35573821
[TBL] [Abstract][Full Text] [Related]
18. Regulatory Roles of Six-Transmembrane Epithelial Antigen of the Prostate Family Members in the Occurrence and Development of Malignant Tumors.
Chen WJ; Wu HT; Li CL; Lin YK; Fang ZX; Lin WT; Liu J
Front Cell Dev Biol; 2021; 9():752426. PubMed ID: 34778263
[TBL] [Abstract][Full Text] [Related]
19. An Elegant Four-Helical Fold in NOX and STEAP Enzymes Facilitates Electron Transport across Biomembranes-Similar Vehicle, Different Destination.
Oosterheert W; Reis J; Gros P; Mattevi A
Acc Chem Res; 2020 Sep; 53(9):1969-1980. PubMed ID: 32815713
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
